{
    "Trade/Device Name(s)": [
        "One Step Single/Multi-drug Test Cup",
        "One Step Single/Multi-drug Test Dipcard"
    ],
    "Submitter Information": "Co-Innovation Biotech Co., Ltd.",
    "510(k) Number": "K131110",
    "Predicate Device Reference 510(k) Number(s)": [
        "K091588"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DKZ",
        "DJC",
        "DIO",
        "LDJ",
        "DKN"
    ],
    "Summary Letter Date": "January 2, 2014",
    "Summary Letter Received Date": "January 2, 2014",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR862.3100",
        "21CFR862.3610",
        "21CFR862.3250",
        "21CFR862.3870",
        "21CFR862.3640"
    ],
    "Regulation Name(s)": [
        "Amphetamine test system"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Amphetamine",
        "Methamphetamine",
        "Cocaine",
        "Cannabinoid",
        "Morphine",
        "Marijuana (THC)"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Lateral flow immunochromatographic assay",
        "Competitive binding immunoassay"
    ],
    "Methodologies": [
        "Antigen-antibody immunochemistry"
    ],
    "Submission Type(s)": [
        "Cup",
        "Dipcard"
    ],
    "Document Summary": "FDA 510(k) summary for One Step Single/Multi-drug Test Cup and Dipcard for qualitative urine drug screening using lateral flow immunoassay",
    "Indications for Use Summary": "Qualitative detection of drugs and drug metabolites (amphetamine, methamphetamine, cocaine, marijuana/THC, morphine) in human urine for clinical laboratory prescription use only, not point-of-care",
    "fda_folder": "Toxicology"
}